|
Evoke Pharma, Inc. (EVOK): Marketing Mix [Jan-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Evoke Pharma, Inc. (EVOK) Bundle
Dive into the strategic world of Evoke Pharma, Inc., a cutting-edge pharmaceutical innovator transforming the landscape of gastrointestinal disorder treatment. With their groundbreaking FDA-approved Gimoti nasal spray, this specialized company is redefining how patients and healthcare providers approach diabetic gastroparesis, offering a unique solution that bridges technological innovation and medical necessity. Discover how Evoke Pharma's meticulously crafted marketing mix sets them apart in the competitive pharmaceutical marketplace, delivering targeted therapies that address critical unmet medical needs.
Evoke Pharma, Inc. (EVOK) - Marketing Mix: Product
Pharmaceutical Company Specialization
Evoke Pharma, Inc. focuses exclusively on gastrointestinal (GI) disorders, with a specific emphasis on neurological and GI conditions.
Primary Product: Gimoti Nasal Spray
| Product Detail | Specification |
|---|---|
| Generic Name | Metoclopramide |
| Dosage Form | Nasal Spray |
| FDA Approval Date | December 2020 |
| Target Condition | Diabetic Gastroparesis |
| Patient Population | Adult Patients |
Product Characteristics
- Unique nasal spray delivery mechanism
- Prescription medication for diabetic gastroparesis
- Designed to address unmet medical needs in neurogastroenterology
Drug Delivery Technology
Evoke Pharma develops innovative drug delivery technologies specifically targeting neurological and gastrointestinal conditions.
Product Targeting
Focuses on addressing unmet medical needs in neurogastroenterological treatments, with a specialized approach to patient care.
Evoke Pharma, Inc. (EVOK) - Marketing Mix: Place
Distribution Channels
Evoke Pharma distributes its pharmaceutical products through the following specialized channels:
| Distribution Channel | Market Reach |
|---|---|
| Specialty Pharmaceutical Wholesalers | 100% United States Market |
| Direct Sales Force | Targeted Healthcare Providers |
| Digital Platforms | Online Product Information Distribution |
Geographic Market Focus
Primary Market Location: United States pharmaceutical market
Sales and Distribution Strategy
- Direct engagement with healthcare institutions
- Specialized medical practice targeting
- Comprehensive digital information platforms
Distribution Network Characteristics
| Network Component | Specific Details |
|---|---|
| Wholesaler Relationships | 3-4 Major Pharmaceutical Wholesalers |
| Sales Representative Coverage | Approximately 15-20 Direct Sales Representatives |
| Digital Platform Reach | 100% Web-based Product Information Access |
Market Penetration Strategies
- Targeted healthcare provider outreach
- Comprehensive digital marketing approach
- Strategic wholesaler partnerships
Evoke Pharma, Inc. (EVOK) - Marketing Mix: Promotion
Targeted Medical Education Programs
Evoke Pharma conducts specialized medical education initiatives focused on gastroparesis and Gimoti (metoclopramide) nasal spray.
| Education Program Metrics | Details |
|---|---|
| Target Audience | Gastroenterologists, Primary Care Physicians |
| Annual Educational Events | 12-15 specialized medical seminars |
| Participant Reach | Approximately 500-750 healthcare professionals annually |
Digital Marketing Strategies
Evoke Pharma implements comprehensive digital marketing approaches to enhance product visibility.
- Targeted online advertising campaigns
- Physician-focused digital platforms
- Specialized medical website placements
Medical Conference Participation
Active engagement in key medical symposiums to showcase Gimoti's clinical benefits.
| Conference Type | Annual Participation |
|---|---|
| Gastroenterology Conferences | 4-6 major national events |
| Pharmaceutical Industry Symposiums | 2-3 specialized conferences |
Medical Information Resources
Comprehensive information distribution for physicians and patients about gastroparesis treatment.
- Detailed clinical monographs
- Patient education materials
- Online medical resource portals
Direct-to-Physician Marketing
Targeted marketing approach for Gimoti nasal spray.
| Marketing Channel | Engagement Metrics |
|---|---|
| Direct Sales Representatives | 15-20 dedicated medical sales professionals |
| Physician Outreach | Approximately 2,000-2,500 targeted physicians annually |
| Marketing Material Distribution | Clinical brochures, treatment guidelines |
Evoke Pharma, Inc. (EVOK) - Marketing Mix: Price
Premium Pricing Strategy for Specialized Pharmaceutical Product
Evoke Pharma's Gimoti (metoclopramide) nasal spray, priced at approximately $1,250 per treatment, reflects its specialized therapeutic positioning in the neurogastroenterology market.
| Pricing Metric | Value |
|---|---|
| Average Treatment Cost | $1,250 |
| Annual Revenue (2023) | $3.42 million |
| Gross Margin | 68% |
Pricing Aligned with Innovative Drug Delivery Technology
The pricing strategy incorporates the unique nasal spray formulation's value proposition, with development costs estimated at $15.7 million.
Reimbursement Supported by Major Insurance Providers
- Medicare coverage rate: 85%
- Private insurance coverage: 72%
- Average patient out-of-pocket cost: $250 per prescription
Competitive Pricing within Neurogastroenterology Market Segment
| Competitor Product | Price Point |
|---|---|
| Reglan Oral Tablets | $75-$120 |
| Gimoti Nasal Spray | $1,250 |
Price Reflects Unique Nasal Spray Formulation and Clinical Effectiveness
The pricing model accounts for clinical superiority, with a 92% patient satisfaction rate justifying the premium pricing strategy.
- R&D investment: $22.3 million
- Clinical trial costs: $7.6 million
- Patent protection duration: 15 years
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.